U.S. market Open. Closes in 6 hours 25 minutes

GENE | Genetic Technologies Limited Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
Revenue7.66M8.69M6.79M120.55K9.86K25.44K189.25K518.51K824.59K2.01M4.56M3.38M3.69M18.28M9.76M11.39M15.74M13.76M9.90M9.47M3.78M9.26M13.11M5.63M4.02M
Cost of Revenue3.76M4.34M321.22K361.03K251.51K276.27K300.09K492.42K743.06K891.24K1.84M1.95M1.95M2.03M2.72M2.20M891.43K6.56M8.07M4.61M3.19MN/AN/AN/AN/A
Gross Profit3.90M4.35M6.47M-240.47K-241.65K-250.82K-110.83K26.09K81.53K1.12M2.73M1.43M1.74M16.24M7.04M9.19M14.84M7.19M1.83M4.85M594.57KN/AN/AN/AN/A
Operating Expenses16.11M12.30M3.11M7.00M6.03M5.91M5.87M7.94M8.64M10.88M12.58M10.58M12.76M15.19M14.72M17.43M16.79M8.75M8.00M12.62M8.25M13.59M21.98M9.06M6.82M
Selling, General & Admin12.83M11.72M4.07M5.28M4.70M4.41M4.08M5.83M6.72M9.16M10.50M12.08M11.26M10.81M10.00M11.55M10.66MN/AN/AN/AN/A348.80K224.57KN/AN/A
Research & Development752.75K1.28M705.51K3.11M2.48M2.36M2.21M2.37M2.58M2.85M3.30M3.46M4.03M4.38M90.00K748.25K1.27M4.52M3.79M2.40M2.37M1.22M1.06M300.00KN/A
Other Operating Expenses2.54M-1.76M-1.66M-1.39M-1.14M-856.71K-426.26K-253.16K-660.35K-1.14M-1.22M-4.97M-2.53MN/A4.63M5.13M4.86M4.23M4.21M10.23M5.88M12.02M20.70M8.76M6.82M
Operating Income-12.21M-9.92M-4.29M-7.06M-6.08M-6.00M-5.98M-8.00M-8.56M-9.76M-9.85M-9.15M-11.02M1.05M-7.68M-8.24M-1.95M-1.56M-6.17M-7.77M-7.66M-4.33M-8.88M-3.43M-2.81M
Other Expenses / Income192.99K-3.72M-2.87M-14.05K-14.82K-427.51K527.05K-408.45K103.34K945.19K-281.22K-204.26K5.72M-146.14K-1.67M-1.50M-3.52M120.06K852.54K537.03K839.40KN/A-10.49K-12.68K-4.30K
Before Tax Income-12.02M-11.91M-7.16M-7.08M-6.10M-6.43M-5.46M-8.40M-8.46M-8.81M-10.13M-9.35M-5.30M901.34K-9.36M-9.74M-5.46M-1.44M-5.32M-7.23M-6.82M-4.33M-8.89M-3.44M-2.81M
Income Tax Expenses-1.99M-158.33K-32.12K130.32K205.15K407.48K542.27KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A246.23K91.17K256.18K39.45KN/AN/AN/AN/A
Net Income-12.02M-11.75M-7.13M-7.21M-6.30M-6.83M-5.46M-8.40M-8.46M-8.81M-10.13M-9.30M-5.29M910.00K-9.34M-7.84M-5.46M-1.67M-5.42M-7.53M-6.89M-4.33M-8.82M-3.39M-2.44M
Interest Expenses51.62K29.52K15.21K14.05K14.82K20.03K28.84K32.00K28.89K264.69K744.20K38.97K45.22K81.93K100.42K89.50K66.91K61.83K85.33K41.64KN/AN/A10.49K12.68KN/A
Basic Shares Outstanding132.22M101.38M92.20M85.44M41.55M28.24M4.06M3.79M3.06M1.92M1.03M843.01K822.15K722.51K680.29K666.76K647.12K647.12K647.12K562.97K496.08K467.04K463.95K463.95K463.95K
Diluted Shares Outstanding132.22M101.38M92.20M85.44M41.55M28.24M4.06M3.79M3.06M1.92M1.03M843.01K822.15K722.51K680.29K666.76K647.12K647.12K647.12K588.73K496.08K467.04K463.95K463.95K463.95K
EBITDA-11.43M-9.24M-3.71M-7.06M-6.08M-6.00M-5.96M-8.00M-8.04M-8.31M-9.04M-8.86M-4.68M1.61M-5.54M-3.76M-625.51K356.50K-2.85M-5.74M-6.22M-841.52K-4.72M88.71K-2.15M
EBITDA Margin-149.13%-106.36%-54.64%-5,859.26%-61,679.92%-23,573.70%-3,150.30%-1,542.94%-975.03%-413.20%-198.12%-262.38%-126.80%8.80%-56.75%-33.03%-3.98%2.59%-28.78%-60.62%-164.50%-9.08%-36.01%1.57%-53.49%
EBIT-13.95M-11.88M-7.15M-7.06M-6.08M-6.41M-4.89M-8.37M-8.43M-8.55M-9.38M-9.26M-5.24M991.94K-9.24M-7.75M-5.39M-1.36M-5.24M-7.23M-6.85M-4.33M-8.81M-3.38M-2.44M
EBIT Margin-182.04%-136.77%-105.20%-5,859.26%-61,679.92%-25,175.18%-2,585.29%-1,614.61%-1,022.34%-424.74%-205.53%-274.18%-142.02%5.43%-94.74%-68.03%-34.26%-9.87%-52.95%-76.40%-181.06%-46.69%-67.25%-59.97%-60.71%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙